GAIN THERAPEUTICS, INC Income Taxes Paid
GAIN THERAPEUTICS, INC (GANX) reported Income Taxes Paid of $47.55 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-03-26
- GAIN THERAPEUTICS, INC income taxes paid, net for fiscal 2025 was $47.55K, a 44.91% decline from fiscal 2024.
- GAIN THERAPEUTICS, INC income taxes paid, net for fiscal 2024 was $86.31K, a 36.05% decline from fiscal 2023.
- GAIN THERAPEUTICS, INC income taxes paid, net for fiscal 2023 was $134.96K, a 4825.62% increase from fiscal 2022.
- GAIN THERAPEUTICS, INC income taxes paid, net for fiscal 2022 was $2.74K, a 38.69% decline from fiscal 2021.
| Period end | Income Taxes Paid, Net 12 month |
|---|---|
| 2025-12-31 | $47.55K 10-K · filed 2026-03-26 |
| 2024-12-31 | $86.31K 10-K · filed 2026-03-26 |
| 2023-12-31 | $134.96K 10-K · filed 2025-03-27 |
| 2022-12-31 | $2.74K 10-K · filed 2024-03-26 |
| 2021-12-31 | $4.47K 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |